4-溴-2-碘苯酚 | 207115-22-8

• 物质功能分类: 有机原料 - 醇、酚、酚醇类化合物及衍生物 - 酚醇类极其卤化、磺化、硝化或亚硝化衍生物
• 分子结构分类: 有机化合物 - 苯类化合物 - 酚类
• 中文名称: 4-溴-2-碘苯酚
• 中文别名: 2-碘-4-溴苯酚
• 英文名称: 4-bromo-2-iodophenol
• CAS: 207115-22-8
• 化学式: C₆H₄BrIO
• 分子量: 298.906
• InChiKey: UXIULWIJWDJDQD-UHFFFAOYSA-N

物化性质

• 熔点：
  90℃ (ethanol )
• 沸点：
  243.0±25.0℃ (760 Torr)
• 密度：
  2.369±0.06 g/cm3 (20 ºC 760 Torr)
• 闪点：
  100.8±23.2℃

计算性质

• 辛醇/水分配系数(LogP)：
  2.7
• 重原子数：
  9
• 可旋转键数：
  0
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  20.2
• 氢给体数：
  1
• 氢受体数：
  1

安全信息

• 危险性防范说明：
  P261,P305+P351+P338
• 危险性描述：
  H302,H315,H319
• 储存条件：
  室温和干燥环境

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: 4-Bromo-2-iodophenol
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: 4-Bromo-2-iodophenol
CAS number: 207115-22-8

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels, refrigerated.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C6H4BrIO
Molecular weight: 298.9

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, hydrogen bromide, hydrogen Iodide.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

制备方法与用途

应用

4-溴-2-碘苯酚又称为2-碘-4-溴苯酚，是一种有机中间体。它可以由对溴苯酚经过硝化、还原及重氮化碘代反应制备得到。

制备

1. 2-硝基-4-溴苯酚的合成： 在化学反应釜中加入对溴苯酚后，在室温下直接加入稀硝酸，静置20分钟后进行减压分馏。收集在125℃、2.35kPa下的馏分即可得到2-硝基-4-溴苯酚。

2. 2-胺基-4-溴苯酚的合成： 将2-硝基-4-溴苯酚置于化学反应釜中，然后向其中加入Fe和稀HCL，并加热至70℃持续1小时。之后进行减压分馏，收集在105℃、2.57kPa下的馏分以获得2-胺基-4-溴苯酚。

3. 4-溴-2-碘苯酚的合成： 在反应釜中加入稍过量的NaNO₂和HI，随后加入2-胺基-4-溴苯酚，并保持0℃进行还原反应。持续时间为40分钟。最后通过减压分馏收集120℃、3.45kPa下的馏分即可得到4-溴-2-碘苯酚。

反应信息

• 作为反应物：
  描述：

  4-溴-2-碘苯酚 在 palladium diacetate 、 4,5-双二苯基膦-9,9-二甲基氧杂蒽 乙醇 、 potassium carbonate 、 caesium carbonate 、 tin(ll) chloride 作用下， 以 四氢呋喃 、 N,N-二甲基甲酰胺 为溶剂， 反应 16.0h， 生成 2,7-dibromo-10H-phenoxazine
  参考文献：
  名称：

  [EN] FUSED TRICYCLIC COMPOUNDS AND USE THEREOF FOR TREATING VIRAL DISEASES
  [FR] COMPOSÉS TRICYCLIQUES CONDENSÉS ET LEUR UTILISATION POUR LE TRAITEMENT DE MALADIES VIRALES

  摘要：

  公开了公式（I）的融合三环化合物及其药用盐，其中X1、X2、X3、X4、Y1、Y2、M1、M2、Ra、Rb、R1、R2和R6的定义如描述中所述。还公开了包含至少一种融合三环化合物的组合物以及使用这些融合三环化合物治疗或预防患者HCV感染的方法。

  公开号：

  WO2012003642A1
• 作为产物：
  描述：

  4-溴苯酚 在 ammonium cerium(IV) nitrate 、 碘 作用下， 反应 4.0h， 以85%的产率得到4-溴-2-碘苯酚
  参考文献：
  名称：

  碘和催化硝酸铈铵对活化芳烃的温和简单区域选择性加碘

  摘要：

  在催化量的CAN的存在下，分子碘已被有效地用于在温和的反应条件下对活化的芳香族化合物进行区域选择性碘化。

  DOI：

  10.1016/j.tetlet.2006.11.009

文献信息

• [EN] (2-((2-ALKOXY) -PHENYL) -CYCLOPENT-1-ENYL) AROMATIC CARBO AND HETEROCYCLIC ACID AND DERIVATIVES<br/>[FR] ACIDE (2-((2-ALCOXY) -PHENYL) -CYCLOPENT-1-ENYL) AROMATIQUE CARBOCYCLIQUE AND HETEROCYCLIQUE ET SES DERIVES
  申请人：GLAXO GROUP LTD

  公开号：WO2003084917A1

  公开（公告）日：2003-10-16

  Compounds of formula (I) or a pharmaceutically acceptable derivative thereof: (I) wherein A, R1 , R2 , Rx , R8 , R9 and n are as defined in the specification, a process for the preparation of such compounds, pharmaceutical compositions comprising such compounds and the use of such compounds in medicine.

  式(I)或其药学上可接受的衍生物的化合物：其中A、R1、R2、Rx、R8、R9和n如规范中所定义，一种制备这种化合物的方法，包括这种化合物的药物组合物以及这种化合物在医学上的用途。
• [EN] 2-ARYLOXYETHYL GLYCINE DERIVATIVES AND THEIR USE AS GLYCINE TRANSPORT INHIBITORS<br/>[FR] DERIVES DE LA 2-ARYLOXYETHYL GLYCINE ET LEUR UTILISATION COMME INHIBITEURS DU TRANSPORT DE LA GLYCINE
  申请人：LILLY CO ELI

  公开号：WO2005100301A1

  公开（公告）日：2005-10-27

  The present invention relates to certain 2-aryloxyethyl glycine derivatives that exhibit activity as inhibitors of the glycine type-1 transporter, to pharmaceutical compositions containing them and to their use in the treatment of neurological and neuropsychiatric disorder.

  本发明涉及某些2-芳氧基乙基甘氨酸衍生物，它们作为甘氨酸类型-1转运体的抑制剂具有活性，涉及含有它们的药物组合物，以及它们在治疗神经学和神经精神障碍中的用途。
• Eco-friendly oxyiodination of aromatic compounds using ammonium iodide and hydrogen peroxide
  作者：N. Narender、K. Suresh Kumar Reddy、K.V.V. Krishna Mohan、S.J. Kulkarni

  DOI：10.1016/j.tetlet.2007.06.138

  日期：2007.8

  A new eco-friendly procedure for the oxyiodination of aromatic compounds with NH4I as an iodine source and H2O2 as an oxidant without any catalyst is presented.

  提出了一种新的环保方法，无需任何催化剂，即可使用NH 4 I作为碘源和H 2 O 2作为氧化剂对芳族化合物进行氧碘化。
• INHIBITORS OF FATTY ACID AMIDE HYDROLASE
  申请人：INFINITY PHARMACEUTICALS, INC.

  公开号：US20150368278A1

  公开（公告）日：2015-12-24

  The present invention provides compounds, and pharmaceutically acceptable compositions thereof, encompassed by any of formulae (I), (II), (III), (IV), (V), or (VI), or subgenera thereof. The present invention also provides methods for treating an FAAH mediated disease, disorder or condition by administering a therapeutically effective amount of a compound or composition comprising a compound of any of formulae (I), (II), (III), (IV), (V), or (VI), or subgenera thereof, to a patient in need thereof. Additionally, the present invention provides methods for inhibiting FAAH by administering a therapeutically effective amount of a compound or composition comprising a compound of any of formulae (I), (II), (III), (IV), (V), or (VI), or subgenera thereof, to a patient in need thereof.

  本发明提供了由任何公式（I）、（II）、（III）、（IV）、（V）或（VI）中的任何化合物及其药学上可接受的组合物所包含的范围，或其亚属所包含的范围。本发明还提供了通过向需要的患者投与任何公式（I）、（II）、（III）、（IV）、（V）或（VI）中的任何化合物或其组合物的治疗有效量来治疗FAAH介导的疾病、紊乱或症状的方法。此外，本发明提供了通过向需要的患者投与任何公式（I）、（II）、（III）、（IV）、（V）或（VI）中的任何化合物或其组合物的治疗有效量来抑制FAAH的方法。
• Iodine(III)-Mediated, Controlled Di- or Monoiodination of Phenols
  作者：Yuvraj Satkar、Luisa F. Yera-Ledesma、Narendra Mali、Dipak Patil、Pedro Navarro-Santos、Luis A. Segura-Quezada、Perla I. Ramírez-Morales、César R. Solorio-Alvarado

  DOI：10.1021/acs.joc.9b00161

  日期：2019.4.5

  An oxidative procedure for the electrophilic iodination of phenols was developed by using iodosylbenzene as a nontoxic iodine(III)-based oxidant and ammonium iodide as a cheap iodine atom source. A totally controlled monoiodination was achieved by buffering the reaction medium with K3PO4. This protocol proceeds with short reaction times, at mild temperatures, in an open flask, and generally with high

  通过使用碘基苯作为无毒的碘（III）基氧化剂和碘化铵作为廉价的碘原子源，开发了一种用于亲电子碘化苯酚的氧化方法。通过用K 3 PO 4缓冲反应介质来实现完全受控的单碘化。在温和的温度下，在开放的烧瓶中，该方案以较短的反应时间进行，并且通常收率很高。用富电子和贫电子的酚以及杂环探索了革兰氏反应以及该方案的范围。量子化学计算显示，PhII（OH）·NH 3是最可能的碘化活性物质，呈反应性“ I +synthon。鉴于碘代芳烃部分的相关性，我们在本文中提出了实用，有效和简单的方法，其具有允许进入碘代芳烃核心单元的宽泛的官能团范围。